Biallelic Deleterious BRCA1 Mutations in a Woman With Early-Onset Ovarian Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-12-0421
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Breast Cancer 1 Early Onset (BRCA1)

Science-Business eXchange
2014English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease

American Journal of Human Genetics
Genetics
2016English

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Frequency of BRCA1 Mutations in B&H Breast and Ovarian Cancer Patients

Genetics & Applications
2018English

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Detection of BRCA1/2 Mutations in Circulating Tumor DNA From Patients With Ovarian Cancer | Ratajska | Oncotarget

Oncotarget
Oncology
2017English

A Novel BRCA1 Mutation in a Spanish Patient With Ovarian Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy